- Published on
Emergency And Acute Medicine – Dementia
Basics And Description
Dementia is a chronic, progressive deterioration in cognition, behavior, or both that is severe enough to interfere with activities of daily living and occurs without impairment of consciousness. It represents a progressive form of organic brain syndrome due to alterations in cortical brain function. More than 50 etiologies exist, with over 60% of cases caused by Alzheimer disease, which is associated with increased neurofibrillary tangles and elevated beta-amyloid plaques. Prevalence rises from approximately 1% at age 60 years to 30–50% by age 85 years. The condition is characterized by a gradual cognitive decline over years, though the course is variable. Rapid decline suggests alternative etiologies or rare rapidly progressive dementias such as prion disease or progressive supranuclear palsy. There is variable hereditary contribution, with increased risk of Alzheimer disease in first-degree relatives. Apolipoprotein ε4 is the only well-established mutation linked to late-onset Alzheimer disease.
Etiology
Primary dementias include cortical types such as Alzheimer disease and frontotemporal dementia, and subcortical types such as Huntington disease, Parkinson disease, and progressive supranuclear palsy. Secondary dementias result from cerebrovascular disease including multi-infarct dementia, toxic, metabolic, or nutritional derangements, prion disorders such as Creutzfeldt–Jakob disease, infectious causes including HIV and syphilis, vasculitic disorders such as systemic lupus erythematosus and thrombotic thrombocytopenic purpura, traumatic causes including chronic subdural hematomas and pugilistic dementia, and structural causes such as normal pressure hydrocephalus and brain masses. Binswanger disease is also included. Approximately 15% of cases are potentially reversible, including normal pressure hydrocephalus, medication effects, intracranial masses, and alcohol-related syndromes. Pseudodementia, often due to depression in elderly patients, can mimic dementia and is suggested by a short duration of symptoms, pinpoint onset, prior psychiatric history, and emphasis on perceived failures.
Diagnosis – Signs And Symptoms
Dementia typically has an insidious onset, often beginning with anxiety, depression, frustration, and increasing forgetfulness. It is frequently preceded by mild cognitive impairment, an intermediate state between normal aging and dementia. Clinical progression is commonly divided into early, moderate, and severe stages. Early disease presents with difficulty concentrating, memory deficits, impaired complex task performance, and social withdrawal. Moderate disease involves major memory impairment and need for assistance with activities of daily living. Severe disease is marked by minimal verbal communication, difficulty eating, and loss of psychomotor skills. Diagnostic criteria require memory impairment plus at least one additional cognitive disturbance such as aphasia, apraxia, agnosia, or executive dysfunction, with deficits causing significant functional decline and not occurring exclusively during delirium.
History
A thorough history must include collateral information from family or caregivers, complete medication review, comorbid conditions, prior similar behaviors, and details regarding onset and progression. Cognitive screening tools such as the Montreal Cognitive Assessment or Short Test of Mental Status may be useful.
Physical Examination
A comprehensive head-to-toe physical examination is required, with special emphasis on a detailed neurologic exam including mental status, cranial nerves, reflexes, motor and sensory function, cerebellar testing, and gait assessment.
Essential Workup
The primary goal is exclusion of acute reversible or exacerbating conditions. The extent of evaluation depends on whether dementia is newly diagnosed, rapidly worsening, or previously established and stable. Clinicians must actively assess for reversible causes.
Diagnosis Tests And Interpretation
Laboratory evaluation for new diagnosis or sudden deterioration includes complete blood count, ESR or CRP, comprehensive metabolic panel, ammonia, urinalysis, toxicology screen, thyroid-stimulating hormone, vitamin B12, syphilis serology, HIV testing, blood cultures if febrile, urine cultures if febrile, and antinuclear antibody testing if systemic lupus erythematosus is suspected. Imaging in these cases may include chest radiograph, noncontrast or contrast-enhanced head CT, EEG if seizures are suspected, and brain MRI or MRA in selected patients. Advanced imaging such as PET is reserved for specialist evaluation. In stable, previously diagnosed dementia, testing may not be required. Lumbar puncture and cerebrospinal fluid analysis are indicated when infection or inflammatory disease is suspected.
Differential Diagnosis
Consider toxic, metabolic, or nutritional abnormalities including narcotics, sedatives, alcohol, heavy metals, dehydration, and electrolyte disorders. Other considerations include pseudodementia, delirium, and normal aging. Delirium should be strongly suspected in febrile patients, especially with urinary tract infection or pneumonia.
Treatment – Prehospital Care
Obtain collateral history from family or caregivers, ensure patient and staff safety, manage agitation, and address comorbid conditions. Treat acute metabolic or toxic disturbances such as hypoglycemia, hypothermia, or hyperthermia.
Initial Stabilization And Therapy
Ensure airway patency, provide supplemental oxygen if hypoxic, stabilize vital signs, and establish IV access as needed. Safety measures are essential in agitated patients.
Emergency Department Treatment And Procedures
Determine whether there is an acute change in mental status and evaluate broadly for reversible causes. Treat hypoglycemia with dextrose, opioid toxicity with naloxone, hypothermia with rewarming, and hyperthermia with antipyretics. Administer IV fluids for dehydration and correct electrolyte abnormalities. Treat infections promptly, with urinary tract infections and pneumonia being common occult sources. Manage seizures with appropriate anticonvulsants. Agitation should be managed with the lowest effective doses of medications, prioritizing safety and minimizing polypharmacy. Treat depression when present.
Medication Management
Cholinesterase inhibitors should be initiated at the lowest dose and include donepezil, rivastigmine, and galantamine, with monitoring for gastrointestinal side effects. Memantine may be considered in patients with poor response to anticholinesterase agents. Antidepressants may be useful but carry risk of oversedation. For agitation, options include haloperidol, risperidone, ziprasidone, lorazepam, or midazolam, always starting at low doses. Naloxone should be used when opioid toxicity is suspected.
Follow-Up And Disposition
Admission is indicated for unstable vital signs, significant comorbid illness requiring parenteral therapy, unclear diagnosis requiring inpatient evaluation, or inadequate home support. Discharge may be considered for patients with stable vital signs, no life-threatening condition identified, secure diagnosis, adequate caregiver support, and reliable follow-up.
Follow-Up Recommendations
Follow-up care should be arranged with primary care, geriatrics, psychiatry, or neurology as appropriate. Social support needs, including transportation and financial assistance, should be addressed.
Key Clinical Lessons And Common Errors
Primary dementia typically follows a slow, steady progression over 5–10 years but may fluctuate due to intercurrent illness. Cholinesterase inhibitors can modestly improve function in Alzheimer disease. Vigilant management of medications, comorbidities, and early treatment of infections improves quality of life and survival. Death most commonly results from infection, cardiovascular disease, or injury.
Basics And Description
Dementia is a chronic, progressive deterioration in cognition, behavior, or both that is severe enough to interfere with activities of daily living and occurs without impairment of consciousness. It represents a progressive form of organic brain syndrome due to alterations in cortical brain function. More than 50 etiologies exist, with over 60% of cases caused by Alzheimer disease, which is associated with increased neurofibrillary tangles and elevated beta-amyloid plaques. Prevalence rises from approximately 1% at age 60 years to 30–50% by age 85 years. The condition is characterized by a gradual cognitive decline over years, though the course is variable. Rapid decline suggests alternative etiologies or rare rapidly progressive dementias such as prion disease or progressive supranuclear palsy. There is variable hereditary contribution, with increased risk of Alzheimer disease in first-degree relatives. Apolipoprotein ε4 is the only well-established mutation linked to late-onset Alzheimer disease.
Etiology
Primary dementias include cortical types such as Alzheimer disease and frontotemporal dementia, and subcortical types such as Huntington disease, Parkinson disease, and progressive supranuclear palsy. Secondary dementias result from cerebrovascular disease including multi-infarct dementia, toxic, metabolic, or nutritional derangements, prion disorders such as Creutzfeldt–Jakob disease, infectious causes including HIV and syphilis, vasculitic disorders such as systemic lupus erythematosus and thrombotic thrombocytopenic purpura, traumatic causes including chronic subdural hematomas and pugilistic dementia, and structural causes such as normal pressure hydrocephalus and brain masses. Binswanger disease is also included. Approximately 15% of cases are potentially reversible, including normal pressure hydrocephalus, medication effects, intracranial masses, and alcohol-related syndromes. Pseudodementia, often due to depression in elderly patients, can mimic dementia and is suggested by a short duration of symptoms, pinpoint onset, prior psychiatric history, and emphasis on perceived failures.
Diagnosis – Signs And Symptoms
Dementia typically has an insidious onset, often beginning with anxiety, depression, frustration, and increasing forgetfulness. It is frequently preceded by mild cognitive impairment, an intermediate state between normal aging and dementia. Clinical progression is commonly divided into early, moderate, and severe stages. Early disease presents with difficulty concentrating, memory deficits, impaired complex task performance, and social withdrawal. Moderate disease involves major memory impairment and need for assistance with activities of daily living. Severe disease is marked by minimal verbal communication, difficulty eating, and loss of psychomotor skills. Diagnostic criteria require memory impairment plus at least one additional cognitive disturbance such as aphasia, apraxia, agnosia, or executive dysfunction, with deficits causing significant functional decline and not occurring exclusively during delirium.
History
A thorough history must include collateral information from family or caregivers, complete medication review, comorbid conditions, prior similar behaviors, and details regarding onset and progression. Cognitive screening tools such as the Montreal Cognitive Assessment or Short Test of Mental Status may be useful.
Physical Examination
A comprehensive head-to-toe physical examination is required, with special emphasis on a detailed neurologic exam including mental status, cranial nerves, reflexes, motor and sensory function, cerebellar testing, and gait assessment.
Essential Workup
The primary goal is exclusion of acute reversible or exacerbating conditions. The extent of evaluation depends on whether dementia is newly diagnosed, rapidly worsening, or previously established and stable. Clinicians must actively assess for reversible causes.
Diagnosis Tests And Interpretation
Laboratory evaluation for new diagnosis or sudden deterioration includes complete blood count, ESR or CRP, comprehensive metabolic panel, ammonia, urinalysis, toxicology screen, thyroid-stimulating hormone, vitamin B12, syphilis serology, HIV testing, blood cultures if febrile, urine cultures if febrile, and antinuclear antibody testing if systemic lupus erythematosus is suspected. Imaging in these cases may include chest radiograph, noncontrast or contrast-enhanced head CT, EEG if seizures are suspected, and brain MRI or MRA in selected patients. Advanced imaging such as PET is reserved for specialist evaluation. In stable, previously diagnosed dementia, testing may not be required. Lumbar puncture and cerebrospinal fluid analysis are indicated when infection or inflammatory disease is suspected.
Differential Diagnosis
Consider toxic, metabolic, or nutritional abnormalities including narcotics, sedatives, alcohol, heavy metals, dehydration, and electrolyte disorders. Other considerations include pseudodementia, delirium, and normal aging. Delirium should be strongly suspected in febrile patients, especially with urinary tract infection or pneumonia.
Treatment – Prehospital Care
Obtain collateral history from family or caregivers, ensure patient and staff safety, manage agitation, and address comorbid conditions. Treat acute metabolic or toxic disturbances such as hypoglycemia, hypothermia, or hyperthermia.
Initial Stabilization And Therapy
Ensure airway patency, provide supplemental oxygen if hypoxic, stabilize vital signs, and establish IV access as needed. Safety measures are essential in agitated patients.
Emergency Department Treatment And Procedures
Determine whether there is an acute change in mental status and evaluate broadly for reversible causes. Treat hypoglycemia with dextrose, opioid toxicity with naloxone, hypothermia with rewarming, and hyperthermia with antipyretics. Administer IV fluids for dehydration and correct electrolyte abnormalities. Treat infections promptly, with urinary tract infections and pneumonia being common occult sources. Manage seizures with appropriate anticonvulsants. Agitation should be managed with the lowest effective doses of medications, prioritizing safety and minimizing polypharmacy. Treat depression when present.
Medication Management
Cholinesterase inhibitors should be initiated at the lowest dose and include donepezil, rivastigmine, and galantamine, with monitoring for gastrointestinal side effects. Memantine may be considered in patients with poor response to anticholinesterase agents. Antidepressants may be useful but carry risk of oversedation. For agitation, options include haloperidol, risperidone, ziprasidone, lorazepam, or midazolam, always starting at low doses. Naloxone should be used when opioid toxicity is suspected.
Follow-Up And Disposition
Admission is indicated for unstable vital signs, significant comorbid illness requiring parenteral therapy, unclear diagnosis requiring inpatient evaluation, or inadequate home support. Discharge may be considered for patients with stable vital signs, no life-threatening condition identified, secure diagnosis, adequate caregiver support, and reliable follow-up.
Follow-Up Recommendations
Follow-up care should be arranged with primary care, geriatrics, psychiatry, or neurology as appropriate. Social support needs, including transportation and financial assistance, should be addressed.
Key Clinical Lessons And Common Errors
Primary dementia typically follows a slow, steady progression over 5–10 years but may fluctuate due to intercurrent illness. Cholinesterase inhibitors can modestly improve function in Alzheimer disease. Vigilant management of medications, comorbidities, and early treatment of infections improves quality of life and survival. Death most commonly results from infection, cardiovascular disease, or injury.
0 Comments
